Galderma has introduced the first-and-only shaper to the hyaluronic acid (HA) market with Restylane Shaype, now approved in the European Union (EU) for chin augmentation1
Restylane Shaype is the firmest HA gel available, powered by new NASHA HD technology, engineered to build and shape on bone for instant, natural-looking lower-face shaping from any angle1-3
It is the latest addition to the innovative Restylane portfolio – the world’s most diverse range of hyaluronic acid injectables designed to meet evolving aesthetic needs, backed by three decades of science4
ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD) today announced that Restylane Shaype has been approved in the EU under the Medical Device Regulation for temporary augmentation of the chin region. Engineered for deep injection to build and shape on bone, Restylane Shaype delivers a unique bone-mimicking effect, enabling immediate, natural-looking structural enhancement in the lower face without surgery.1-3
The lower face plays a pivotal role in overall facial balance, influencing proportions and profile.2 This region is an increasing area of concern for patients, with around one in four people expressing concerns related to lower face sagging and chin shape.5 When asked about their facial priorities, a third of people pointed out issues with their chin shape – a key contributor to facial definition and structural harmony.5 Genetic factors and age-related changes can lead to reduced chin definition and poor projection.2,6 Until now, achieving structure in this area has largely relied on surgical implants, with no minimally invasive injectable aesthetic alternatives available for patients.2
Powered by Galderma’s new NASHA HD™ technology, Restylane Shaype is the firmest HA injectable gel available among market leaders in the facial filler market, with the highest G’ (measure of firmness) of the Restylane range.2,3 As the first-and-only HA dermal filler specifically designed to allow aesthetic injectors to build and shape on the lower angles of the face, it provides greater projection with lower injection volumes.2,7,8 Underpinning the Restylane range is a minimally modified HA gel that closely resembles naturally occurring HA, requires less product than other HA gels, and can be readily reversed, offering both performance and reassurance.2,9-13
|
“Hyaluronic acid fillers remain the irreplaceable hero at the center of modern aesthetic care, yet the ability to achieve structural support in the face without surgery has long been limited. In my clinical practice, I have seen how Restylane Shaype can address this gap, supported by pivotal data demonstrating durable improvements in lower face structure and definition through 12 months, high patient satisfaction and strong willingness to repeat treatment. These findings mirror what I have been seeing in practice and highlight the value of a bone-mimicking HA injectable that enables predictable, natural-looking results aligned with individual patient anatomy and treatment goals.”
DR. ANDREI METELITSA, MD, FRCPC, DABD, COSMETIC DERMATOLOGIST RESTYLANE SHAYPE PIVOTAL STUDY INVESTIGATOR CANADA |
|
